CME Group Inc. (NASDAQ:CME) Launches Leveraged Loan Index Futures
CME Group Inc. (CME) launched S&P UBS USD Liquid Leveraged Loan Index futures on Sept. 14, enabling cross-margining with rate and equity futures. The move expands CME's credit derivatives offerings, following a 2024 launch.
How this was made

The 30-second read
Why it matters
The new futures contract could generate incremental fee revenue and strengthen CME's market position in credit products.
Market read
First‑time launch of a leveraged loan futures series adds a novel trading instrument, offering potential revenue upside for CME and new exposure for market participants.
What to watch
Margin requirements and cross‑margining complexities may deter some traders.
Background
CME Group continues its strategy to broaden credit derivative offerings after the 2024 launch of related products.
Ticker impact
CME Group launched S&P UBS USD Liquid Leveraged Loan Index futures on Sept. 14.
CME stock may see modest upside as market participants allocate to the new product.
First‑time launch of a leveraged loan futures series adds a high‑margin product to CME's platform, likely attracting institutional flow.
Market effects
Adds depth to the credit derivatives sector and may increase competition for loan‑related products.
U.S. futures markets gain a new leveraged loan instrument, potentially drawing global participants.
Enhances CME's global product suite, signaling broader interest in leveraged loan exposure.
Counterpoint
Initial volumes may be low; the product could face regulatory scrutiny limiting adoption.
Key entities
- CompanyCME Group Inc.
Operator of the new leveraged loan futures contract.
- Index ProviderS&P UBS
Provider of the underlying leveraged loan index.


